Data for this analysis were obtained from the Parkinson’s Progression Markers Initiative (PPMI). we analyzed the November 2023 PPMI data release, applying the following key exclusion criteria to ...
Fibrosing interstitial lung diseases (fILDs) exhibit diverse clinical courses and prognoses, with no established biomarkers for predicting acute exacerbation (AE) and early death. This study ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results